Q4 2024 Management View CEO Paula Ragan highlighted 2024 as a transformative year for X4 Pharmaceuticals, with the U.S. approval and launch of XOLREMDI (mavorixafor) for WHIM syndrome, a rare ...

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line ...

Tempero Bio was created in 2020 by the venture firm Aditum Bio to advance the clinical development of a portfolio of potent, ...

German software company SAP overtook Danish healthcare company Novo Nordisk as Europe's largest company by market ...

Stocks like Reliance Industries, Apollo Hospitals Enterprise, Power Grid Corporation, Allied Blenders and Distillers, ...

The White House called it “the latest massive victory in President Donald J. Trump’s unrelenting pursuit of American manufacturing dominance,” ...

P/E of the Market' concept is absolute baloney. It fails miserably to stand up to any analytical and conceptual rigor. It is ...

Taoiseach Micheál Martin’s trip to the US is coming to an end today after an eventful few days. From his meeting with ...

Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...

Taoiseach Micheál Martin met US president Donald Trump yesterday in a hotly anticipated meeting as part of St Patrick’s Day ...

The program has been at a center of a yearslong lobbying battle between hospitals and pharmaceutical companies, with each ...